Refresh

WOCKHARDT LTD. - Announcement under Regulation 30 (LODR)-Press Release / Media Release


Download
19 Sep 2024
Please find enclosed Press Release titled, "Wockhardt''s Investigational Drug, Zaynich (Zidebactam/Cefepime) cures complex case of meningitis caused by pan-drug resistant super-bug under compassionate use".

Source: BSE India

View all announcements for WOCKHARDT LTD.
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com